news
Drug linked to 33 deaths in Northern Ireland is reclassified
The prescription drug pregabalin is now being treated as a class C drug...
List view / Grid view
pregabalin
news
Pfizer reports top-line results from a Phase 3 study evaluating pregabalin controlled-release formulation as a treatment for patients with postherpetic neuralgia
19 December 2014 | By Pfizer
Pfizer Inc. (NYSE:PFE) announced today top-line results from a double-blind Phase 3 study evaluating pregabalin controlled-release (CR) formulation in adult patients with postherpetic neuralgia (pain after shingles or PHN).
news
Pfizer reports top-line results from two Lyrica® capsules CV phase 3b studies
The study met its primary endpoint, showing a statistically significant greater reduction in fibromyalgia pain...
news
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release as treatment for patients with fibromyalgia
19 November 2012 | By Pfizer
Top-line results of a Phase 3 study...
news
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release formulation as adjunctive treatment in adult patients with partial onset seizures
16 November 2012 | By Pfizer
Pfizer Inc., announced top-line results of a double-blind, placebo-controlled, Phase 3 study...
news
Pfizer and Northwestern University win LYRICA® patent case
19 July 2012 | By Pfizer
“The Court’s decision recognizes the infringement & validity of our LYRICA® patents..."
news
Pfizer exploratory study measures effects of Lyrica (pregabalin) on brain activity in fibromyalgia patients
18 May 2012 | By Pfizer
Results of studies on Lyrica® announced...
news
Pfizer stops Phase 3 trial Of Lyrica (pregabalin) capsules CV in neuropathic pain associated with HIV neuropathy
4 May 2012 | By Pfizer
Pfizer has stopped a Phase 3 clinical trial of Lyrica in patients with neuropathic pain...
news
Pfizer reports top-line results from Phase 3 trial of Lyrica (pregabalin) capsules CV in patients with inadequately treated painful diabetic peripheral neuropathy
4 May 2012 | By Pfizer
Pfizer announced that a Phase 3 randomized withdrawal design study for Lyrica in patients...
news
Positive top-line results for Pfizer’s Lyrica in Phase 3 Study of patients with Fibromyalgia in Japan
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
news
Pfizer’s Lyrica top-line results positive in global Phase 3 Study
21 June 2011 | By Pfizer
Pfizer Inc. announced that top-line results for Lyrica Study A0081107, demonstrated that the study met its primary endpoint...
